A detailed history of Integrated Quantitative Investments LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Integrated Quantitative Investments LLC holds 10,690 shares of BMY stock, worth $463,839. This represents 0.15% of its overall portfolio holdings.

Number of Shares
10,690
Holding current value
$463,839
% of portfolio
0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

BUY
$44.12 - $59.6 $471,642 - $637,124
10,690 New
10,690 $495 Million
Q4 2024

Feb 12, 2025

BUY
$51.92 - $59.94 $363,440 - $419,580
7,000 New
7,000 $396 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $92.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Integrated Quantitative Investments LLC Portfolio

Follow Integrated Quantitative Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Quantitative Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Quantitative Investments LLC with notifications on news.